Verekitug Recruiting Phase 2 Trials for Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP) Treatment

Indications	Status	Purpose	Phase
DBCOND0121724 (Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP))	Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT06164704	A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps	Verekitug (DB19096)